Comprehensive evaluation of cervical cancer screening programs: The case of Colombia

Salud Publica de Mexico

Volumn 53, Issue 6, 2011, Pages 469-477

  Murillo, Raúl ^a   Wiesner, Carolina ^a   Cendales, Ricardo ^a   Piñeros, Marion ^a   Tovar, Sandra ^a  

^a Instituto Nacional de Cancerología   (Colombia)

Author keywords

Colombia; Cytology; Mass screening; Program evaluation; Uterine cervical neoplasms

Indexed keywords

ADULT; AGED; ARTICLE; CASE CONTROL STUDY; COLOMBIA; EARLY DIAGNOSIS; EVALUATION; FEMALE; HEALTH CARE DELIVERY; HEALTH CARE QUALITY; HUMAN; LABORATORY DIAGNOSIS; MASS SCREENING; METHODOLOGY; MIDDLE AGED; MORTALITY; PATHOLOGY; STANDARD; STATISTICS; UTERINE CERVIX TUMOR; VAGINA SMEAR;

ADULT; AGED; CASE-CONTROL STUDIES; COLOMBIA; EARLY DETECTION OF CANCER; FALSE NEGATIVE REACTIONS; FEMALE; HEALTH SERVICES ACCESSIBILITY; HUMANS; MASS SCREENING; MIDDLE AGED; PROGRAM EVALUATION; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 84856077513     PISSN: 00363634     EISSN: 16067916     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Parkin DM, Bray F. Chapter 2: The burden of HPV-related cancers. Vaccine 2006;24 Suppl 3:S3, S11-S25.
2. Quinn M, Babb P, Jones J, Allen E. Effect of screening on incidence of and mortality from cancer of cervix in England: evaluation based on routinely collected statistics. BMJ 1999;318:904-908.
3. Kitchener HC, Castle PE, Cox JT. Chapter 7: Achievements and limitations of cervical cytology screening. Vaccine 2006;24 Suppl 3:S3, S63-S70.
4. Pardo C, Cendales R. Incidencia estimada y mortalidad por cáncer en Colombia 2002-2006. Bogotá: INC, 2010.
5. Denny L, Quinn M, Sankaranarayanan R. Chapter 8: Screening for cervical cancer in developing countries. Vaccine 2006;24 Suppl 3:S3, S71-S7.
6. Murillo R, Almonte M, Pereira A, Ferrer E, Gamboa OA, Jerónimo J, et al. Cervical cancer screening programs in Latin America and the Caribbean. Vaccine 2008;26 Suppl 11:L37-48.
7. Lazcano-Ponce EC, Buiatti E, Nájera-Aguilar P, Alonso-de-Ruiz P, Hernández-Avila M. Evaluation model of the Mexican national program for early cervical cancer detection and proposals for a new approach. Cancer Causes Control 1998;9:241-251.
8. Madlensky L, Goel V, Polzer J, Ashbury FD. Assessing the evidence for organised cancer screening programmes. Eur J Cancer 2003;39:1648-1653.
9. Marrett LD, Robles S, Ashbury FD, Green B, Goel V, Luciani S. A proposal for cervical screening information systems in developing countries. Int J Cancer 2002;102:293-299.
10. Gamboa OA, Chicaíza L, García-Molina M, Díaz J, González M, Murillo R, et al. Cost-effectiveness of conventional cytology and HPV DNA testing for cervical cancer screening in Colombia. Salud Publica Mex 2008;50:276-285.
11. Gage JC, Ferreccio C, Gonzales M, Arroyo R, Huivín M, Robles SC. Follow-up care of women with an abnormal cytology in a low-resource setting. Cancer Detect Prev 2003;27(6):466-471.
12. Herrero R, Ferreccio C, Salmerón J, Almonte M, Sánchez GI, Lazcano-Ponce E, et al. New approaches to cervical cancer screening in Latin America and the Caribbean. Vaccine 2008;26 Suppl 11:L49-58.
13. Sarian LO, Derchain SF, Naud P, Roteli-Martins C, Longatto-Filho A, Tatti S, et al. Evaluation of visual inspection with acetic acid (VIA), Lugol's iodine (VILI), cervical cytology and HPV testing as cervical screening tools in Latin America. This report refers to partial results from the LAMS (Latin AMerican Screening) study. J Med Screen 2005;12:142-149.
14. Murillo R, Luna J, Gamboa O, Osorio E, Bonilla J, Cendales R, et al. Cervical cancer screening with naked-eye visual inspection in Colombia. Int J Gynaecol Obstet 2010;109(3):230-234.
15. Cuzick J, Clavel C, Petry KU, Meijer CJ, Hoyer H, Ratnam S, et al. Overview of the European and North American studies on HPV testing in primary cervical cancer screening. Int J Cancer 2006;119:1095-1101.
16. Murillo R, Piñeros M, Hernández G. Atlas de mortalidad por cáncer en Colombia. Bogotá: Instituto Nacional de Cancerologia/Instituto Geográfico Agustín Codazzi, 2004.
17. Ministerio de Salud. Indicadores de cumplimiento en las intervenciones de protección específica y detección temprana. Resolución 3384 de 2000. Colombia: Ministerio de Salud, 2004.
18. Wiesner C, Tovar S, Piñeros M, Cendales R, Murillo R. Cervical cancer screening services offered in Colombia. Rev Colomb Cancerol 2009;13(3):134-144.
19. Cendales R, Wiesner C, Murillo RH, Piñeros M, Tovar S, Mejía JC. Quality of vaginal smears for cervical cancer screening: a concordance study. Biomedica 2010;30:107-115.
20. Piñeros M, Cendales R, Murillo R, Wiesner C, Tovar S. Pap test coverage and related factors in Colombia, 2005. Rev Salud Publica (Bogota) 2007;9:327-341.
21. Wiesner C, Cendales R, Murillo R, Piñeros M, Tovar S. Following-up females having an abnormal Pap smear in Colombia. Rev Salud Publica (Bogota) 2010;12:1-13.
22. Murillo R, Cendales R, Wiesner C, Piñeros M, Tovar S. Effectiveness of cytology-based cervical cancer screening in the Colombian health system. Biomedica 2009;29:354-361.
23. Ojeda G, Ordóñez M, Ochoa L, Samper B, Sánchez F. Salud sexual y reproductiva: Encuesta Nacional de Demografía y Salud 2005. Bogotá: Profamilia, Bienestar Familiar, USAID, Ministerio de la Protección Social, 2005.
24. Adab P, McGhee SM, Yanova J, Wong CM, Hedley AJ. Effectiveness and efficiency of opportunistic cervical cancer screening: comparison with organized screening. Med Cares. 2004;42:600-609.
25. Arbyn M, Rebolj M, De Kok IM, Fender M, Becker N, O'Reilly M, et al. The challenges of organising cervical screening programmes in the 15 old member states of the European Union. Eur J Cancer 2009;45:2671-2678.
26. Madlensky L, Goel V, Polzer J, Ashbury FD. Assessing the evidence for organised cancer screening programmes. Eur J Cancer 2003;39(12):1648-1653.
27. Spence AR, Goggin P, Franco EL. Process of care failures in invasive cervical cancer: systematic review and meta-analysis. Prev Med 2007;45(2-3):93-106.
28. Denny L, Kuhn L, Hu CC, Tsai WY, Wright TC Jr. Human Papillomavirus-Based Cervical Cancer Prevention: Long-term Results of a Randomized Screening Trial. J Natl Cancer Inst 2010;102:1-11.
29. Sankaranarayanan R, Nene BM, Shastri SS, Jayant K, Muwonge R, Budukh AM, et al. HPV screening for cervical cancer in rural India. N Engl J Med 2009;360:1385-1394.
30. Public Helath Agency of Canada. Performance monitoring for cervical cancer screening in Canada. Report form the screening performance indictaors working group, Cervical Cancer Prevention and Control Network (CCPCN). Canadá: Health Canada, 2009.
31. Lazcano-Ponce EC, Nájera-Aguilar P, Alonso de Ruiz Pa, Buiatti E, Hernández-Ávila M. Programa de Detección Oportuna de Cáncer Cervical en México. Diagnóstico situacional. Rev Inst Nal Cancerol Mex 1996; 42:123-140.
32. Ronco G, van Ballegooijen M, Becker N, Chil A, Fender M, Giubilato P, et al. Process performance of cervical screening programmes in Europe. Eur J Cancer 2009;45:2659-2670.
33. Andrae B, Kemetli L, Sparén P, Silfverdal L, Strander B, Ryd W, et al. Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden. J Natl Cancer Inst 2008;100(9):622-629.